Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.45
-0.65 (-1.71%)
Jul 30, 2026, 1:30 PM CST

Center Laboratories Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6031,5161,6181,394767.72500.11
Revenue Growth
-1.84%-6.29%16.06%81.58%53.51%-30.25%
Gross Profit
675.06621.26748.95618.09406.27259.66
Operating Income
-426.63-361.62234.0678.56284.12-254.15
Net Income
10,7399,323-1,104-995.42102.221,816
Earnings Per Share
13.3411.44-1.48-1.430.152.64
EPS Growth
-----94.29%-53.20%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fenghua Sector/Department
690.42576.17646.91446.06--
Pharmaceutical Division
915.06941.1971.71950.53767.8500.31
Adjustment and Write-Off
-24.38-24.26-21.57-18.72-1.52-1.64
Shengzhi Venture
22.223.1720.8216.14--
Total
1,6031,5161,6181,394767.72500.11

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,857662.822,0503,4242,3484,849
Total Debt
4,9984,7046,5305,6213,4685,362
Net Cash (Debt)
-1,141-4,041-4,480-2,197-1,120-512.52
Net Cash Growth
------
Net Cash Per Share
-1.41-4.92-6.01-3.15-1.65-0.73

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
127.8227.16394.74-963.44-189.88-358.14
Capital Expenditures
-211.82-205.5-174.17-169.4-7.28-7.55
Free Cash Flow
-84-178.34220.56-1,133-197.16-365.69
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.10%40.98%46.29%44.34%52.92%51.92%
Operating Margin
-26.61%-23.85%14.47%5.63%37.01%-50.82%
Pretax Margin
853.27%763.01%-72.32%-79.91%-76.71%519.02%
Profit Margin
669.82%614.88%-68.22%-71.41%13.31%363.16%
FCF Margin
-5.24%-11.76%13.63%-81.27%-25.68%-73.12%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.7471.7470.7501.4280.8661.889
Dividend Per Share Growth
129.71%132.89%-47.46%64.87%-54.16%83.29%
Dividend Yield
4.58%4.20%1.83%3.55%2.26%4.61%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2.863.33--275.2216.82
Forward PE
-21.7321.7321.7321.7321.73
P/FCF Ratio
--143.23---
PS Ratio
17.7420.4819.5321.9736.6461.10